Bile test for bile duct cancer diagnosis
Part of Cancer clinical trials.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Have a narrowing (stenosis) in the bile duct
- Need a procedure called endoscopic retrograde cholangiography or a radiology procedure to take tissue samples
- Not be pregnant
- Not be under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing if a new protein-based lab test can better identify bile duct cancer from stored tissue samples. It's looking for people who had a bile duct sample taken but don't yet have a clear cancer diagnosis.
This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.
This study is testing a new way to use a simple blood test to help diagnose cholangiocarcinoma (bile duct cancer) earlier and more accurately. It is for people whose tumors can be surgically removed and who have not had prior cancer treatment.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.